Evidence map›Paper›PMID 26844700›Full record

ArticleCell death & disease2016

MicroRNA-222 regulates muscle alternative splicing through Rbm24 during differentiation of skeletal muscle cells.

B Cardinali, M Cappella, C Provenzano, J M Garcia-Manteiga, D Lazarevic, D Cittaro, F Martelli, G Falcone

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. miRNA-Based Regulation of Alternative RNA Splicing in Metazoans.International journal of molecular sciences · 2021
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

B CardinaliInstitute of Cell Biology and Neurobiology, National Research Council, Monterotondo Scalo, Rome, Italy.
M CappellaInstitute of Cell Biology and Neurobiology, National Research Council, Monterotondo Scalo, Rome, Italy.
C ProvenzanoInstitute of Cell Biology and Neurobiology, National Research Council, Monterotondo Scalo, Rome, Italy.
J M Garcia-ManteigaCenter For Translational Genomics and Bioinformatics, San Raffaele Scientific Institute, Milan, Italy.
D LazarevicCenter For Translational Genomics and Bioinformatics, San Raffaele Scientific Institute, Milan, Italy.
D CittaroCenter For Translational Genomics and Bioinformatics, San Raffaele Scientific Institute, Milan, Italy.ORCID http://orcid.org/0000-0003-0384-3700
F MartelliMolecular Cardiology Laboratory, Policlinico San Donato-IRCCS, San Donato Milanese, Milan, Italy.
G FalconeInstitute of Cell Biology and Neurobiology, National Research Council, Monterotondo Scalo, Rome, Italy.
National Research Council · ITIRCCS Policlinico San Donato · IT

Funding

Telethon GGP14092
6 · The paper itself

Abstract

A number of microRNAs have been shown to regulate skeletal muscle development and differentiation. MicroRNA-222 is downregulated during myogenic differentiation and its overexpression leads to alteration of muscle differentiation process and specialized structures. By using RNA-induced silencing complex (RISC) pulldown followed by RNA sequencing, combined with in silico microRNA target prediction, we have identified two new targets of microRNA-222 involved in the regulation of myogenic differentiation, Ahnak and Rbm24. Specifically, the RNA-binding protein Rbm24 is a major regulator of muscle-specific alternative splicing and its downregulation by microRNA-222 results in defective exon inclusion impairing the production of muscle-specific isoforms of Coro6, Fxr1 and NACA transcripts. Reconstitution of normal levels of Rbm24 in cells overexpressing microRNA-222 rescues muscle-specific splicing. In conclusion, we have identified a new function of microRNA-222 leading to alteration of myogenic differentiation at the level of alternative splicing, and we provide evidence that this effect is mediated by Rbm24 protein.

Indexed as

Alternative SplicingCell DifferentiationHumansMicroRNAsMuscle DevelopmentMuscle Fibers, SkeletalRNA-Binding ProteinsMicroRNAsMIR222, humanRBM24 protein, humanRNA-Binding Proteins

Identifiers

PMID26844700
PMCPMC4849150
OpenAlexW2256899852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.